Market News AIOpen the app

LYEL stock news · Lyell Immunopharma, Inc.

Stories about Lyell Immunopharma, Inc. (LYEL) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for LYEL

Follow Lyell Immunopharma, Inc. (LYEL) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for LYEL
Free on the App Store and Google Play, or on the web.
  1. Nov 14, 2026, 9:06 PM ET · Market

    Lyell Immunopharma is letting stockholders sell 7.43 million shares of its common stock.

    Bad for LYEL

    Lyell filed to register 7.43 million existing shares for sale by shareholders. The company gets no money, making this unfavorable for its shares.

  2. Sep 10, 2026, 4:21 PM ET · Market

    Lyell Immunopharma, Inc. shares news about finishing the tech transfer for LYL273.

    Neutral

    Lyell completed the LYL273 manufacturing transfer and noted a trial timeline update; because the filing lacks timeline detail, the filing does not change Lyell's outlook.